Understanding AI's Expanding Role in Drug Dis...

As AI agents move from pilots into live financial workflows, most institutions still can't answer a basic question: who authorized this action, and what evidence backs it up? In this episode, Shahir Daya, Chief Product & Technology Officer at Zafin, examines why uniform governanc ...  Show more

A persistent gap remains between what modern manufacturing technology makes possible and how day‑to‑day work is still executed, with paper workflows, limited machine visibility, and siloed data preventing real operational control. In this episode, Sebastian Dykas, Director of Man ...  Show more

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more

Shai Shen-Orr, co-founder and chief scientist at CytoReason and professor at the Technion, talks about the next frontier in healthcare: disease modeling. Shai shares how CytoReason bridges the gap between exploding biological data and actionable insight, powering smarter, faster ...  Show more

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ...  Show more

GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ...  Show more